Arcellx's anito-cel shows promising efficacy and safety in multiple myeloma. Read why I maintain my hold rating for ACLX ...
Legend Biotech Corporation (NASDAQ:LEGN) has been making waves in the biotechnology sector with its flagship product, ...
Multiple myeloma is a rare, aggressive blood cancer that disproportionately impacts Black men. Despite its increasing ...
Targeted therapies for high-risk leukemia in children have yet to be developed, but scientists at Université de Montréal and ...
Small- and mid-sized companies have consistently trailed large caps, but UBS believes that may change. Here are 40 top ...
According to a recent report from Future Market Insights, the global allogeneic T-cell therapies market was valued at USD 1.1 ...